Back in 2016, Nokia announced it wanted to acquire French wearables and health company Withings. One year and two months later, in June of 2017, the acquisition and assimilation was complete and Withings became Nokia Health and started releasing some more products, the last of which was Nokia Sleep which was introduced at this year’s CES. Now Nokia has announced that it has initiated a strategic review for this Digital Health business.
A newly discovered family of dirt-dwelling antibiotics could be our best weapon against treatment-resistant “superbugs.”
Researchers from Rockefeller University discovered the compounds, which are called malacidins, while analyzing more than 1,000 soil samples from across the United States. When they noticed a number of samples contained malacidins, they decided to dig a bit deeper into the compounds.
After infecting rats with MRSA, a bacteria that’s particularly resistant to most antibiotic treatments, the researchers treated the rodents with malacidins, and the compound eliminated the infection in the animals’ skin wounds. The team’s research has been published in Nature Microbiology.
In December 2016, the United Nations elevated the problem of antibiotic resistance to crisis level, calling it a “fundamental, long-term threat to human health, sustainable food production, and development.”
No corner of the world is immune to the issue, according to the World Health Organization (WHO), and if we don’t do something about it, we could soon find ourselves living in the “post-antibiotic era,” a period in which something as simple as a minor cut could be deadly.
The WHO urges the healthcare industry to develop new antibiotics to combat this issue, and thus far, most of that research has been undertaken in labs. In that respect, the Rockefeller University team’s approach of turning to nature for leads is fairly unique.
“Every place you step, there’s 10,000 bacteria, most of which we’ve never seen,” lead researcher Sean Brady told The Washington Post. “Our idea is, there’s this reservoir of antibiotics out in the environment we haven’t accessed yet.”
The team is now working to improve the effectiveness of their treatment so it could be used in people. However, as Brady told BBC News, that process will be neither quick nor easy.
“It is impossible to say when, or even if, an early stage antibiotic discovery like the malacidins will proceed to the clinic,” said Brady. “It is a long, arduous road from the initial discovery of an antibiotic to a clinically used entity.”
Still, arduous or not, it’s a road worth traveling because an estimated 700,000 people die every year due to drug-resistant superbugs, and that number could increase to as many as 10 million by 2050 if we don’t take action now.
It's easier to appreciate nature when you witness it first-hand, but that's rather difficult with the ocean unless you have a submarine at your disposal. The BBC and Google have a more practical solution: they've launched a BBC Earth: Life in VR ap… Engadget RSS Feed
During its earnings call earlier this month, Google revealed that its device shipments doubled in 2017 compared to 2016, but as usual the company didn’t give us any hard numbers. Thankfully, that hasn’t stopped IDC, one of the big analyst houses, from releasing its estimates. According to Francisco Jeronimo, IDC’s Research Director, Google shipped 3.9 million Pixels last year. The analyst also confirms Google’s own report saying that shipments have indeed doubled. That said, Google is still very far from being anywhere near a market leader in this regard. Given that its distribution…
As fascinating as shoes like Nike's "PlayStation" PG2s or Adidas' "4D" Futurecrafts are, those particular models don't offer many (if any) benefits to avid runners. They're more geared toward sneakerheads than anyone else. But, that doesn't mean ther… Engadget RSS Feed